“Despite a lowering of LDL cholesterol by an … mmol/L during the study, however, allocation to pravastatin was associated … “only” 15% ( SE 7, 95% CI 3–26) in the primary outcome of coronary death, non-fatal … [14·1%] pravastatin vs 473 [16·2%] placebo affected individuals, p=0·014).”